170 related articles for article (PubMed ID: 379623)
1. The mutagenicities of safrole, estragole, eugenol, trans-anethole, and some of their known or possible metabolites for Salmonella typhimurium mutants.
Swanson AB; Chambliss DD; Blomquist JC; Miller EC; Miller JA
Mutat Res; 1979 Apr; 60(2):143-53. PubMed ID: 379623
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole.
Miller EC; Swanson AB; Phillips DH; Fletcher TL; Liem A; Miller JA
Cancer Res; 1983 Mar; 43(3):1124-34. PubMed ID: 6825084
[TBL] [Abstract][Full Text] [Related]
3. The side-chain epoxidation and hydroxylation of the hepatocarcinogens safrole and estragole and some related compounds by rat and mouse liver microsomes.
Swanson AB; Miller EC; Miller JA
Biochim Biophys Acta; 1981 Apr; 673(4):504-16. PubMed ID: 7225430
[TBL] [Abstract][Full Text] [Related]
4. Screening of safrole, eugenol, their ninhydrin positive metabolites and selected secondary amines for potential mutagenicity.
Green NR; Savage JR
Mutat Res; 1978 May; 57(2):115-21. PubMed ID: 351383
[TBL] [Abstract][Full Text] [Related]
5. Mutagenicity of trans-anethole, estragole, eugenol, and safrole in the Ames Salmonella typhimurium assay.
To LP; Hunt TP; Andersen ME
Bull Environ Contam Toxicol; 1982 Jun; 28(6):647-54. PubMed ID: 7049270
[No Abstract] [Full Text] [Related]
6. Structure-activity studies of the hepatocarcinogenicities of alkenylbenzene derivatives related to estragole and safrole on administration to preweanling male C57BL/6J x C3H/HeJ F1 mice.
Wiseman RW; Miller EC; Miller JA; Liem A
Cancer Res; 1987 May; 47(9):2275-83. PubMed ID: 3567921
[TBL] [Abstract][Full Text] [Related]
7. Genotoxicity of safrole-related chemicals in microbial test systems.
Sekizawa J; Shibamoto T
Mutat Res; 1982 Apr; 101(2):127-40. PubMed ID: 6808388
[TBL] [Abstract][Full Text] [Related]
8. Mutagenicity of phenanthrene and phenanthrene K-region derivatives.
Bücker M; Glatt HR; Platt KL; Avnir D; Ittah Y; Blum J; Oesch F
Mutat Res; 1979 Apr; 66(4):337-48. PubMed ID: 379629
[TBL] [Abstract][Full Text] [Related]
9. [Mutagenicity of the metabolites of the epoxide-diol pathway of safrole and its analogs. Study on Salmonella typhimurium].
Dorange JL; Delaforge M; Janiaud P; Padieu P
C R Seances Soc Biol Fil; 1977; 171(5):1041-8. PubMed ID: 146546
[TBL] [Abstract][Full Text] [Related]
10. Hepatocarcinogenicity of estragole (1-allyl-4-methoxybenzene) and 1'-hydroxyestragole in the mouse and mutagenicity of 1'-acetoxyestragole in bacteria.
Drinkwater NR; Miller EC; Miller JA; Pitot HC
J Natl Cancer Inst; 1976 Dec; 57(6):1323-31. PubMed ID: 187802
[TBL] [Abstract][Full Text] [Related]
11. Microsomal metabolism of 1-nitrobenzo[e]pyrene to a highly mutagenic K-region dihydrodiol.
Fu PP; Heflich RH; Von Tungeln LS; Miranda HZ; Evans FE
Carcinogenesis; 1988 Jun; 9(6):951-8. PubMed ID: 3286032
[TBL] [Abstract][Full Text] [Related]
12. The metabolic activation of the carcinogen 1'-hydroxysafrole in vivo and in vitro and the electrophilic reactivities of possible ultimate carcinogens.
Wislocki PG; Borchert P; Miller JA; Miller EC
Cancer Res; 1976 May; 36(5):1686-95. PubMed ID: 5188
[TBL] [Abstract][Full Text] [Related]
13. Effects of the naturally occurring alkenylbenzenes eugenol and trans-anethole on drug-metabolizing enzymes in the rat liver.
Rompelberg CJ; Verhagen H; van Bladeren PJ
Food Chem Toxicol; 1993 Sep; 31(9):637-45. PubMed ID: 8406240
[TBL] [Abstract][Full Text] [Related]
14. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
[TBL] [Abstract][Full Text] [Related]
15. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice.
Randerath K; Haglund RE; Phillips DH; Reddy MV
Carcinogenesis; 1984 Dec; 5(12):1613-22. PubMed ID: 6499112
[TBL] [Abstract][Full Text] [Related]
16. Mutagenicity of nitrofurans in Salmonella typhimurium TA98, TA98NR and TA98/1,8-DNP6.
Ni YC; Heflich RH; Kadlubar FF; Fu PP
Mutat Res; 1987 Sep; 192(1):15-22. PubMed ID: 3309641
[TBL] [Abstract][Full Text] [Related]
17. Hydrolysis of the 2',3'-allylic epoxides of allylbenzene, estragole, eugenol, and safrole by both microsomal and cytosolic epoxide hydrolases.
Luo G; Qato MK; Guenthner TM
Drug Metab Dispos; 1992; 20(3):440-5. PubMed ID: 1521503
[TBL] [Abstract][Full Text] [Related]
18. Chemicals mutagenic in Salmonella typhimurium strain TA1535 but not in TA100.
Prival MJ; Zeiger E
Mutat Res; 1998 Feb; 412(3):251-60. PubMed ID: 9600693
[TBL] [Abstract][Full Text] [Related]
19. Human cytochrome p450 enzyme specificity for the bioactivation of estragole and related alkenylbenzenes.
Jeurissen SM; Punt A; Boersma MG; Bogaards JJ; Fiamegos YC; Schilter B; van Bladeren PJ; Cnubben NH; Rietjens IM
Chem Res Toxicol; 2007 May; 20(5):798-806. PubMed ID: 17407329
[TBL] [Abstract][Full Text] [Related]
20. Comparative induction of unscheduled DNA synthesis in cultured rat hepatocytes by allylbenzenes and their 1'-hydroxy metabolites.
Chan VS; Caldwell J
Food Chem Toxicol; 1992 Oct; 30(10):831-6. PubMed ID: 1427504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
